NDC00378-5632-59: SUMATRIPTAN SUCCINATE TABLETS.
The SUMATRIPTAN SUCCINATE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, primary_container_type: BOTTLE, primary_container_content_quantity: 9.0 TABLETS, active_medicament_medicinal_strength: 100.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9S.. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-727-8704, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| primary_container_content_quantity | 9.0 TABLETS |
| active_medicament_medicinal_strength | 100.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9S. |
| NSN | 6505-01-727-8704 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 9.0 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9 TABLETS. STORE AT 20 TO 25 C (68 TO 77 F). (SEE USP CONTROLLED ROOM TEMPERATURE). PROTECT FROM LIGHT. INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9S. |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT |